Lorimar Ramirez
Pediatric Hematology-Oncology · San Antonio, TXNPI 1629277736
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 29.2% of the total. Reporting peaked in 2024 at $1,387 and has fallen 69.2% since, to $428 in 2025.
Across 89 payments — averaging $48.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1K
- Sobi, Inc$414
- AstraZeneca$400
- Servier Pharmaceuticals LLC$350
- Fennec Pharmaceuticals, Inc.$327
- BTG International Inc.$205
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 24 | $1,253 |
| Sobi, Inc | 4 | $414 |
| AstraZeneca(2 entities) | 6 | $400 |
| Servier Pharmaceuticals LLC | 4 | $350 |
| Fennec Pharmaceuticals, Inc. | 4 | $327 |
| BTG International Inc. | 2 | $205 |
| Amgen(2 entities) | 2 | $162 |
| Sanofi-aventis U.S. LLC | 1 | $148 |
| Novartis | 7 | $144 |
| Adaptive Biotechnologies Corporation | 1 | $128 |
| RARE Disease Therapeutics, Inc. | 1 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Pfizer | 5 | $101 |
| Global Blood Therapeutics, Inc. | 4 | $88 |
| Cumberland Pharmaceuticals, Inc. | 4 | $56 |
| Mirum Pharmaceuticals, Inc. | 3 | $52 |
| Pharming Healthcare, Inc. | 2 | $41 |
| QOL Medical, LLC | 1 | $37 |
| Novo Nordisk | 2 | $31 |
| Bayer | 1 | $29 |
| Duchesnay USA Incorporated | 1 | $24 |
| Day One Biopharmaceuticals | 1 | $22 |
| Y-mabs Therapeutics, Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Sandoz | 1 | $17 |
| USWM, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,298 in reported general payments places this provider in the 75th percentile of 235 pediatric hematology-oncology providers in Texas.
Other pediatric hematology-oncology in San Antonio
- Vinod Gidvani-DiazSan Antonio$101K
- Scott PenneySan Antonio$75K
- Chatchawin AssanasenSan Antonio$65K
- Samuel Pabon RiveraSan Antonio$23K
- Allison GrimesSan Antonio$21K
- Aaron SugalskiSan Antonio$9K
- Ghadir SasaSan Antonio$5K
- Mark GarciaSan Antonio$3K
- Anne-Marie LangevinSan Antonio$3K
- Amanda LipsittSan Antonio$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.